PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials
Jichang Luo(Capital Medical University), Liqun Jiao(Capital Medical University), Xue Wang(Ningxia Hui Autonomous Region Peoples Hospital), Wenjing Li(Changchun University of Chinese Medicine), Yan Ma(Shandong University of Traditional Chinese Medicine), Tao Wang(Yunnan University of Traditional Chinese Medicine), Kaixun Huang(Sun Yat-sen University), Kan Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Yang, Ran Xu(Capital Medical University), Wanying Liao(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Li(Bethune International Peace Hospital)
Cited by 11
Related Papers
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Magnetic EDTA-modified chitosan/SiO2/Fe3O4 adsorbent: Preparation, characterization, and application in heavy metal adsorption
|Chemical Engineering Journal|2013|570
Ancient genomes from northern China suggest links between subsistence changes and human migration
|Nature Communications|2020|342
TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response
|PLoS Genetics|2019|296
Selenoprotein Gene Nomenclature
|Journal of Biological Chemistry|2016|278